Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Sienna Biopharmaceuticals
SNNA

Buy Sienna Biopharmaceuticals (SNNA) Stock

SNNA
See SNNA stock price and Buy/Sell Sienna Biopharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
SNNA

Sienna Biopharmaceuticals (SNNA)

About Sienna Biopharmaceuticals (SNNA)

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by T...Read more
Market Cap
1 Year High
$0.03
Volume
1 Year Low
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch SNNA stock

Sienna Biopharmaceuticals Stock News

Sienna Biopharmaceuticals stock rating

What analysts recommend for SNNA stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

Sienna Biopharmaceuticals price target

What analysts think SNNA will be worth
Low $0
High $5
Current $0
Target $5

Sienna Biopharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.07
-0.15
-0.22
Q4 2019

Expected EPS
Q4 2019
-$0.22
Actual EPS
Q4 2019

Buy Sienna Biopharmaceuticals (SNNA) Stock

SNNA
See SNNA stock price and Buy/Sell Sienna Biopharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch SNNA stock
  • midemartins1 avatar
  • mv67 avatar
  • bladon avatar
  • BrianDC avatar
  • Mike88Lee avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.